
NHS England has widened abiraterone acetate access for adults with high-risk non-metastatic prostate cancer, with treatment expected to reach eligible patients within weeks. The change...

Oral morphine sulphate supplied as Oramorph remains a first-line strong opioid when moderate to severe pain does not respond to weaker agents. The immediate release...